Angiodynamics (ANGO) Long-Term Deferred Tax (2011 - 2016)

Angiodynamics has reported Long-Term Deferred Tax for 6 years, with the latest figure at $19.8 million in Q1 2016.

• For the quarter ending Q1 2016, Long-Term Deferred Tax rose 1.42% year-over-year to $19.8 million; the trailing twelve-month figure through Feb 2016 stood at $19.8 million (up 1.42% YoY), and the FY2015 full-year result was $19.5 million, up 27.87% from the prior year.
• Long-Term Deferred Tax for Q1 2016 stood at $19.8 million, down from $20.0 million in the prior quarter.
• The five-year high for Long-Term Deferred Tax was $44.3 million in Q2 2012, with the low at $5.2 million in Q1 2012.
• Historically, Long-Term Deferred Tax has averaged $18.4 million across 5 years, with a median of $18.0 million in 2013.
• Annual changes were most pronounced in 2012 — Long-Term Deferred Tax surged 683.5% — and 2013, when it tumbled 73.51%.
• Angiodynamics' Long-Term Deferred Tax stood at $38.6 million in 2012, then sank by 75.37% to $9.5 million in 2013, then grew by 24.94% to $11.9 million in 2014, then jumped by 68.8% to $20.0 million in 2015, then decreased by 1.16% to $19.8 million in 2016.
• The last three Long-Term Deferred Tax figures came in at $19.8 million (Q1 2016), $20.0 million (Q4 2015), and $19.7 million (Q3 2015), per Business Quant data.